Tapewire

NYSE · USD

ICE

Intercontinental Exchange, Inc.

Export transactions ↓
Tapewire entity
1809
SEC CIK
0001571949
Parsed reports
941

Last 12 months

Inside the activity.

0 purchase rows · 64 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202505
Dec 202505
Jan 202600
Feb 2026026
Mar 202601
Apr 202600
May 202606
Jun 202602
Jul 202604
Aug 2026010
Sep 202605
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
July 10, 2019 Filed Jul 12, 2019 20:18 UTC
Hill Scott AChief Financial Officer
SaleCommon Stock 33,875 $90.06 $3,050,782.50
Disclosure

SEC source: 0001209191-19-041929 · doc4.xml · nonDerivative · entry 2

Hill Scott A · CIK 0001397778 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 146,920

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F3 · price: The price range for the aggregate amount sold by the direct holder is $90.00 - $90.12. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 112,767 shares of common stock and 34,153 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2019 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and will be reported at the time of vesting. The satisfaction of the 2017, 2018 and 2019 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020, February 2021 and February 2022, respectively, and will be reported at the time of vesting.

Read SEC document
July 10, 2019 Filed Jul 12, 2019 20:18 UTC
Hill Scott AChief Financial Officer
Exercise / conversionCommon Stock 26,375 $22.43 $591,591.25
Disclosure

SEC source: 0001209191-19-041929 · doc4.xml · nonDerivative · entry 1

Hill Scott A · CIK 0001397778 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 180,795

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · balance_after: Amount of securities beneficially owned includes 165 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 28, 2019.

Read SEC document
July 05, 2019 Filed Jul 8, 2019 20:20 UTC
Goone David SChief Strategic Officer
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative 4,450 $0.00 Strike: $22.43 $0.00
Disclosure

SEC source: 0001209191-19-041407 · doc4.xml · derivative · entry 3

Goone David S · CIK 0001343869 · Chief Strategic Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,450 shares

Expires 2022-01-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These options are fully vested.

Read SEC document
July 05, 2019 Filed Jul 8, 2019 20:20 UTC
Goone David SChief Strategic Officer
SaleCommon Stock 9,405 $89.01 $837,131.53
Disclosure

SEC source: 0001209191-19-041407 · doc4.xml · nonDerivative · entry 2

Goone David S · CIK 0001343869 · Chief Strategic Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 162,740

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · price: The price range for the aggregate amount sold by the direct holder is $89.00 - $89.06. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 134,705 shares of common stock and 28,035 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2019 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and will be reported at the time of vesting. The satisfaction of the 2017, 2018 and 2019 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020, February 2021 and February 2022, respectively, and will be reported at the time of vesting.

Read SEC document
July 05, 2019 Filed Jul 8, 2019 20:20 UTC
Goone David SChief Strategic Officer
Exercise / conversionCommon Stock 4,450 $22.43 $99,813.50
Disclosure

SEC source: 0001209191-19-041407 · doc4.xml · nonDerivative · entry 1

Goone David S · CIK 0001343869 · Chief Strategic Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 172,145

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

Read SEC document
July 02, 2019 Filed Jul 3, 2019 17:29 UTC
Vice Charles AVice Chairman
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative 15,000 $0.00 Strike: $57.31 $0.00
Disclosure

SEC source: 0001209191-19-040783 · doc4.xml · derivative · entry 4

Vice Charles A · CIK 0001343884 · Vice Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,412

Underlying: Common Stock · 15,000 shares

Expires 2027-01-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: These options are fully vested.

Read SEC document
July 02, 2019 Filed Jul 3, 2019 17:29 UTC
Vice Charles AVice Chairman
SaleCommon Stock 128 $87.29 $11,173.12
Disclosure

SEC source: 0001209191-19-040783 · doc4.xml · nonDerivative · entry 3

Vice Charles A · CIK 0001343884 · Vice Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 406,936

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 358,510 shares of common stock and 48,426 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2019 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and will be reported at the time of vesting. The satisfaction of the 2017, 2018 and 2019 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020, February 2021 and February 2022, respectively, and will be reported at the time of vesting.

Read SEC document
July 02, 2019 Filed Jul 3, 2019 17:29 UTC
Vice Charles AVice Chairman
SaleCommon Stock 14,872 $86.74 $1,289,992.82
Disclosure

SEC source: 0001209191-19-040783 · doc4.xml · nonDerivative · entry 2

Vice Charles A · CIK 0001343884 · Vice Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 407,064

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F3 · price: The price range for the aggregate amount sold by the direct holder is $86.275 - $87.24. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

Read SEC document
July 02, 2019 Filed Jul 3, 2019 17:29 UTC
Vice Charles AVice Chairman
Exercise / conversionCommon Stock 15,000 $57.31 $859,650.00
Disclosure

SEC source: 0001209191-19-040783 · doc4.xml · nonDerivative · entry 1

Vice Charles A · CIK 0001343884 · Vice Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 421,936

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · balance_after: Amount of securities beneficially owned includes 165 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 28, 2019.

Read SEC document
June 06, 2019 Filed Jun 7, 2019 20:20 UTC
Martin Lynn CPresident & COO, ICE Data Serv
SaleCommon Stock 135 $85.10 $11,488.50
Disclosure

SEC source: 0001209191-19-035538 · doc4.xml · nonDerivative · entry 2

Martin Lynn C · CIK 0001754817 · President & COO, ICE Data Serv

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,360

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 14,813 shares of common stock and 13,547 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2019 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and will be reported at the time of vesting. The satisfaction of the 2017, 2018 and 2019 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020, February 2021 and February 2022, respectively, and will be reported at the time of vesting.

Read SEC document
June 06, 2019 Filed Jun 7, 2019 20:19 UTC SaleCommon Stock 2,075 $85.00 $176,381.43
Disclosure

SEC source: 0001209191-19-035536 · doc4.xml · nonDerivative · entry 2

Jackson Benjamin · CIK 0001722067 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,449

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F3 · price: The price range for the aggregate amount sold by the direct holder is $85.00 - $85.02. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 44,938 shares of common stock, 2,838 unvested restricted stock units ("RSUs"), and 23,673 unvested performance based restricted stock units ("PSU's"), for which the performance period has been satisfied. The RSUs and the PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2019 PSUs tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and will be reported at the time of vesting. The satisfaction of the 2017, 2018 and 2019 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020, February 2021 and February 2022, respectively, and will be reported at the time of vesting.

Read SEC document
June 06, 2019 Filed Jun 7, 2019 20:19 UTC
Hill Scott AChief Financial Officer
SaleCommon Stock 4,247 $85.01 $361,023.88
Disclosure

SEC source: 0001209191-19-035535 · doc4.xml · nonDerivative · entry 2

Hill Scott A · CIK 0001397778 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 154,255

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · price: The price range for the aggregate amount sold by the direct holder is $85.00 - $85.06. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 120,102 shares of common stock and 34,153 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2019 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and will be reported at the time of vesting. The satisfaction of the 2017, 2018 and 2019 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020, February 2021 and February 2022, respectively, and will be reported at the time of vesting.

Read SEC document
June 05, 2019 Filed Jun 6, 2019 20:22 UTC
Surdykowski Andrew JGeneral Counsel
SaleCommon Stock 1,000 $85.00 $85,000.00
Disclosure

SEC source: 0001209191-19-035065 · doc4.xml · nonDerivative · entry 1

Surdykowski Andrew J · CIK 0001755922 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,861

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 33,744 shares of common stock and 6,117 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2019 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and will be reported at the time of vesting. The satisfaction of the 2017, 2018 and 2019 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020, February 2021 and February 2022, respectively, and will be reported at the time of vesting.

Read SEC document
June 05, 2019 Filed Jun 7, 2019 20:20 UTC
Martin Lynn CPresident & COO, ICE Data Serv
SaleCommon Stock 2,365 $85.00 $201,025.00
Disclosure

SEC source: 0001209191-19-035538 · doc4.xml · nonDerivative · entry 1

Martin Lynn C · CIK 0001754817 · President & COO, ICE Data Serv

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,495

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

Read SEC document
June 05, 2019 Filed Jun 7, 2019 20:19 UTC SaleCommon Stock 2,925 $85.00 $248,625.59
Disclosure

SEC source: 0001209191-19-035536 · doc4.xml · nonDerivative · entry 1

Jackson Benjamin · CIK 0001722067 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,524

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · price: The price range for the aggregate amount sold by the direct holder is $85.00 - $85.01. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

Read SEC document
June 05, 2019 Filed Jun 7, 2019 20:19 UTC
Hill Scott AChief Financial Officer
SaleCommon Stock 3,253 $85.00 $276,505.00
Disclosure

SEC source: 0001209191-19-035535 · doc4.xml · nonDerivative · entry 1

Hill Scott A · CIK 0001397778 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 158,502

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

Read SEC document
June 03, 2019 Filed Jun 4, 2019 20:32 UTC
Vice Charles AVice Chairman
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative 20,000 $0.00 Strike: $57.31 $0.00
Disclosure

SEC source: 0001209191-19-034287 · doc4.xml · derivative · entry 3

Vice Charles A · CIK 0001343884 · Vice Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,412

Underlying: Common Stock · 20,000 shares

Expires 2027-01-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These options are fully vested.

Read SEC document
June 03, 2019 Filed Jun 4, 2019 20:32 UTC
Vice Charles AVice Chairman
SaleCommon Stock 20,000 $82.29 $1,645,846.00
Disclosure

SEC source: 0001209191-19-034287 · doc4.xml · nonDerivative · entry 2

Vice Charles A · CIK 0001343884 · Vice Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 406,771

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · price: The price range for the aggregate amount sold by the direct holder is $81.955 - $82.62. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 358,345 shares of common stock and 48,426 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2019 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and will be reported at the time of vesting. The satisfaction of the 2017, 2018 and 2019 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020, February 2021 and February 2022, respectively, and will be reported at the time of vesting.

Read SEC document
June 03, 2019 Filed Jun 4, 2019 20:32 UTC
Vice Charles AVice Chairman
Exercise / conversionCommon Stock 20,000 $57.31 $1,146,200.00
Disclosure

SEC source: 0001209191-19-034287 · doc4.xml · nonDerivative · entry 1

Vice Charles A · CIK 0001343884 · Vice Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 426,771

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

Read SEC document
May 29, 2019 Filed May 30, 2019 20:24 UTC
TESE VINCENTDirector
GiftCommon Stock 1,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-033430 · doc4.xml · nonDerivative · entry 2

TESE VINCENT · CIK 0001042445 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,004

F2 · shares: This transaction involved a gift of 1,000 shares of the Issuer's common stock by the reporting person to a philanthropic organization.

F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 31,420 shares of common stock and 2,584 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 17, 2020.

Read SEC document
May 29, 2019 Filed May 30, 2019 20:24 UTC
TESE VINCENTDirector
SaleCommon Stock 2,000 $81.87 $163,739.20
Disclosure

SEC source: 0001209191-19-033430 · doc4.xml · nonDerivative · entry 1

TESE VINCENT · CIK 0001042445 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,004

F1 · price: The price range for the aggregate amount sold by the direct holder is $81.86 - $81.89. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

Read SEC document
May 23, 2019 Filed May 28, 2019 20:26 UTC SaleCommon Stock 2,445 $81.10 $198,279.72
Disclosure

SEC source: 0001209191-19-032987 · doc4.xml · nonDerivative · entry 1

CRISP CHARLES R · CIK 0001015825 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,152

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · price: The price range for the aggregate amount sold by the direct holder is $80.74 - $81.34. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 50,875 shares of common stock and 2,445 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 17, 2020.

Read SEC document
May 23, 2019 Filed May 28, 2019 20:27 UTC SaleCommon Stock 839 $81.14 $68,077.47
Disclosure

SEC source: 0001209191-19-032992 · doc4.xml · nonDerivative · entry 1

Hague William Jefferson · CIK 0001652762 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,104

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · price: The price range for the aggregate amount sold by the direct holder is $80.79 - $81.44. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 9,520 shares of common stock and 2,584 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 17, 2020.

Read SEC document
May 23, 2019 Filed May 28, 2019 20:28 UTC SaleCommon Stock 2,794 $81.04 $226,418.22
Disclosure

SEC source: 0001209191-19-032996 · doc4.xml · nonDerivative · entry 1

SPRIESER JUDITH A · CIK 0001206994 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,064

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · price: The price range for the aggregate amount sold by the direct holder is $80.74 - $81.34. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 24,480 shares of common stock and 2,584 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 17, 2020.

Read SEC document
May 23, 2019 Filed May 28, 2019 20:28 UTC SaleCommon Stock 2,794 $81.09 $226,562.95
Disclosure

SEC source: 0001209191-19-032993 · doc4.xml · nonDerivative · entry 1

Hatfield Fred W · CIK 0001399286 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,065

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · price: The price range for the aggregate amount sold by the direct holder is $80.74 - $81.31. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 31,481 shares of common stock and 2,584 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 17, 2020.

Read SEC document
May 23, 2019 Filed May 28, 2019 20:26 UTC SaleCommon Stock 1,222 $81.10 $99,099.80
Disclosure

SEC source: 0001209191-19-032990 · doc4.xml · nonDerivative · entry 1

Forneri Jean Marc · CIK 0001343872 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,800

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · price: The price range for the aggregate amount sold by the direct holder is $80.77 - $81.42. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 20,523 shares of common stock and 2,277 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 17, 2020.

Read SEC document
May 22, 2019 Filed May 23, 2019 20:24 UTC
Sprecher Jeffrey CDirector · Chief Executive Officer
SaleCommon Stock 2,285 $81.26 $185,675.90
Disclosure

SEC source: 0001209191-19-032297 · doc4.xml · nonDerivative · entry 3

Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By spouse

Disclosed balance after: 111,092

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F7 · price: The price range for the aggregate amount sold by the direct holder is $81.07 - $81.58. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F8 · balance_after: The common stock number referred in Table I is an aggregate number and represents 99,869 shares of common stock, 7,733 unvested restricted stock units ("RSUs"), and and 3,490 unvested performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2017 and 2018 total shareholder return PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and February 2021, respectively, and will be reported at the time of vesting.

F9 · balance_after: As previously reported, the reporting person also indirectly owns 3,671,705 shares that are beneficially owned directly by CPEX. The reporting person beneficially owns 100% of the equity interest in CPEX. Additionally, as previously reported, the reporting person also beneficially owns shares directly.

Read SEC document
May 22, 2019 Filed May 23, 2019 20:24 UTC
Sprecher Jeffrey CDirector · Chief Executive Officer
SaleCommon Stock 20,000 $81.26 $1,625,276.00
Disclosure

SEC source: 0001209191-19-032297 · doc4.xml · nonDerivative · entry 2

Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · CPEX

Disclosed balance after: 3,671,705

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F5 · price: The price range for the aggregate amount sold by the direct holder is $81.04 - $81.70. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F6 · balance_after: These shares are beneficially owned directly by CPEX. Mr. Sprecher beneficially owns 100% of the equity interest in CPEX directly. Additionally, as previously reported, the reporting person also owns shares directly and indirectly owns shares that are beneficially owned directly by the reporting person's spouse for which the reporting person disclaims beneficial ownership.

Read SEC document
May 22, 2019 Filed May 23, 2019 20:24 UTC
Sprecher Jeffrey CDirector · Chief Executive Officer
SaleCommon Stock 30,881 $81.26 $2,509,482.70
Disclosure

SEC source: 0001209191-19-032297 · doc4.xml · nonDerivative · entry 1

Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,475,328

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · price: The price range for the aggregate amount sold by the direct holder is $81.05 - $81.71. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 1,365,734 shares of common stock and 109,594 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2019 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and will be reported at the time of vesting. The satisfaction of the 2017, 2018 and 2019 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020, February 2021 and February 2022, respectively, and will be reported at the time of vesting.

F4 · balance_after: As previously reported, the reporting person also indirectly owns 3,671,705 shares that are beneficially owned directly by Continental Power Exchange, Inc. ("CPEX"). The reporting person beneficially owns 100% of the equity interest in CPEX. Additionally, as previously reported, the reporting person indirectly owns shares that are beneficially owned directly by the reporting person's spouse for which the reporting person disclaims beneficial ownership.

Read SEC document
May 20, 2019 Filed May 22, 2019 20:22 UTC Tax withholdingCommon Stock 193 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-032048 · doc4.xml · nonDerivative · entry 1

Hague William Jefferson · CIK 0001652762 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,943

F1 · shares: Represents shares of common stock underlying vested restricted stock units that are being withheld to satisfy payment of the Issuer's tax withholding obligation.

F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 10,359 shares of common stock and 2,584 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 17, 2020.

Read SEC document
May 17, 2019 Filed May 21, 2019 21:18 UTC GrantCommon Stock 2,277 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-031795 · doc4.xml · nonDerivative · entry 1

CRISP CHARLES R · CIK 0001015825 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,597

F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share.

F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 53,320 shares of common stock and 2,277 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 17, 2020.

Read SEC document
May 17, 2019 Filed May 21, 2019 21:08 UTC GrantCommon Stock 2,277 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-031790 · doc4.xml · nonDerivative · entry 1

NOONAN THOMAS E · CIK 0001079742 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,787

F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share.

F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 8,510 shares of common stock and 2,277 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 17, 2020.

Read SEC document
May 17, 2019 Filed May 21, 2019 21:20 UTC
TESE VINCENTDirector
GrantCommon Stock 2,584 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-031801 · doc4.xml · nonDerivative · entry 1

TESE VINCENT · CIK 0001042445 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,004

F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share. Of the 2,584 restricted stock units awarded, 2,277 were awarded as compensation for service on the Issuer's board and 307 were awarded as compensation for service on the board of Issuer's subsidiary, ICE Clear Credit LLC.

F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 34,420 shares of common stock and 2,584 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 17, 2020.

Read SEC document
May 17, 2019 Filed May 21, 2019 17:09 UTC GrantCommon Stock 2,277 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-031793 · doc4.xml · nonDerivative · entry 1

SALERNO FREDERIC V · CIK 0001180138 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,197

F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share.

F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 10,920 shares of common stock and 2,277 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 17, 2020.

Read SEC document
May 17, 2019 Filed May 21, 2019 21:07 UTC GrantCommon Stock 2,277 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-031788 · doc4.xml · nonDerivative · entry 1

Farooqui Duriya M · CIK 0001699994 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,672

F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share.

F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 5,395 shares of common stock and 2,277 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 17, 2020.

Read SEC document
May 17, 2019 Filed May 21, 2019 21:18 UTC GrantCommon Stock 2,584 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-031796 · doc4.xml · nonDerivative · entry 1

Hague William Jefferson · CIK 0001652762 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,136

F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share. Of the 2,584 restricted stock units awarded, 2,277 were awarded as compensation for service on the Issuer's board and 307 were awarded as compensation for service on the board of Issuer's subsidiary, ICE Futures Europe.

F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 10,552 shares of common stock and 2,584 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 17, 2020.

Read SEC document
May 17, 2019 Filed May 21, 2019 21:19 UTC GrantCommon Stock 2,584 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-031800 · doc4.xml · nonDerivative · entry 1

SPRIESER JUDITH A · CIK 0001206994 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,858

F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share. Of the 2,584 restricted stock units awarded, 2,277 were awarded as compensation for service on the Issuer's board and 307 were awarded as compensation for service on the board of Issuer's subsidiary, ICE Clear Credit LLC.

F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 27,274 shares of common stock and 2,584 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 17, 2020.

Read SEC document
May 17, 2019 Filed May 21, 2019 21:19 UTC GrantCommon Stock 2,584 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-031798 · doc4.xml · nonDerivative · entry 1

Hatfield Fred W · CIK 0001399286 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,859

F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share. Of the 2,584 restricted stock units awarded, 2,277 were awarded as compensation for service on the Issuer's board and 307 were awarded as compensation for service on the board of Issuer's subsidiary, ICE Clear Credit LLC.

F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 34,275 shares of common stock and 2,584 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 17, 2020.

Read SEC document
May 17, 2019 Filed May 21, 2019 21:08 UTC GrantCommon Stock 2,277 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-031789 · doc4.xml · nonDerivative · entry 1

Forneri Jean Marc · CIK 0001343872 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,022

F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share.

F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 21,745 shares of common stock and 2,277 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 17, 2020.

Read SEC document
May 17, 2019 Filed May 21, 2019 21:06 UTC
Bowen SharonDirector
GrantCommon Stock 2,277 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-031785 · doc4.xml · nonDerivative · entry 1

Bowen Sharon · CIK 0001724974 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,189

F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share.

F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 4,912 shares of common stock and 2,277 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 17, 2020.

Read SEC document
May 08, 2019 Filed May 10, 2019 20:32 UTC SaleCommon Stock 300 $80.79 $24,236.01
Disclosure

SEC source: 0001209191-19-028938 · doc4.xml · nonDerivative · entry 2

Jackson Benjamin · CIK 0001722067 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,449

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F3 · price: The price range for the aggregate amount sold by the direct holder is $80.77 - $80.80. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 49,938 shares of common stock, 2,838 unvested restricted stock units ("RSUs"), and 23,673 unvested performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and the PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2019 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and will be reported at the time of vesting. The satisfaction of the 2017, 2018 and 2019 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020, February 2021 and February 2022, respectively, and will be reported at the time of vesting.

Read SEC document
May 08, 2019 Filed May 10, 2019 20:32 UTC SaleCommon Stock 1,155 $80.42 $92,880.25
Disclosure

SEC source: 0001209191-19-028938 · doc4.xml · nonDerivative · entry 1

Jackson Benjamin · CIK 0001722067 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,749

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · price: The price range for the aggregate amount sold by the direct holder is $79.74 - $80.73. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

Read SEC document
May 02, 2019 Filed May 3, 2019 20:17 UTC
Vice Charles AVice Chairman
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative 20,000 $0.00 Strike: $57.31 $0.00
Disclosure

SEC source: 0001209191-19-027342 · doc4.xml · derivative · entry 4

Vice Charles A · CIK 0001343884 · Vice Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,412

Underlying: Common Stock · 20,000 shares

Expires 2027-01-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: These options are fully vested.

Read SEC document
May 02, 2019 Filed May 3, 2019 20:17 UTC
Vice Charles AVice Chairman
SaleCommon Stock 2,700 $80.99 $218,674.08
Disclosure

SEC source: 0001209191-19-027342 · doc4.xml · nonDerivative · entry 3

Vice Charles A · CIK 0001343884 · Vice Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 406,771

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F3 · price: The price range for the aggregate amount sold by the direct holder is $80.75 - $81.34. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 358,345 shares of common stock and 48,426 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2019 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and will be reported at the time of vesting. The satisfaction of the 2017, 2018 and 2019 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020, February 2021 and February 2022, respectively, and will be reported at the time of vesting.

Read SEC document
May 02, 2019 Filed May 3, 2019 20:17 UTC
Vice Charles AVice Chairman
SaleCommon Stock 17,300 $80.28 $1,388,880.33
Disclosure

SEC source: 0001209191-19-027342 · doc4.xml · nonDerivative · entry 2

Vice Charles A · CIK 0001343884 · Vice Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 409,471

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · price: The price range for the aggregate amount sold by the direct holder is $79.73 - $80.65. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

Read SEC document
May 02, 2019 Filed May 3, 2019 20:17 UTC
Vice Charles AVice Chairman
Exercise / conversionCommon Stock 20,000 $57.31 $1,146,200.00
Disclosure

SEC source: 0001209191-19-027342 · doc4.xml · nonDerivative · entry 1

Vice Charles A · CIK 0001343884 · Vice Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 426,771

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

Read SEC document
April 26, 2019 Filed Apr 29, 2019 20:24 UTC
Surdykowski Andrew JGeneral Counsel
GiftCommon Stock 300 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-026415 · doc4.xml · nonDerivative · entry 2

Surdykowski Andrew J · CIK 0001755922 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,861

F3 · shares: This transaction involved a gift of 300 shares of the Issuer's common stock by the reporting person to a philanthropic organization.

F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 34,744 shares of common stock and 6,117 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2019 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and will be reported at the time of vesting. The satisfaction of the 2017, 2018 and 2019 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020, February 2021 and February 2022, respectively, and will be reported at the time of vesting.

Read SEC document
April 26, 2019 Filed Apr 29, 2019 20:24 UTC
Surdykowski Andrew JGeneral Counsel
SaleCommon Stock 1,200 $81.00 $97,197.00
Disclosure

SEC source: 0001209191-19-026415 · doc4.xml · nonDerivative · entry 1

Surdykowski Andrew J · CIK 0001755922 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,161

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · price: The price range for the aggregate amount sold by the direct holder is $80.77 - $81.09. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

Read SEC document
April 17, 2019 Filed Apr 18, 2019 20:01 UTC
Hill Scott AChief Financial Officer
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative 11,675 $0.00 Strike: $22.50 $0.00
Disclosure

SEC source: 0001209191-19-025231 · doc4.xml · derivative · entry 3

Hill Scott A · CIK 0001397778 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,675 shares

Expires 2021-01-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These options are fully vested.

Read SEC document
April 17, 2019 Filed Apr 18, 2019 20:01 UTC
Hill Scott AChief Financial Officer
SaleCommon Stock 11,675 $80.02 $934,185.63
Disclosure

SEC source: 0001209191-19-025231 · doc4.xml · nonDerivative · entry 2

Hill Scott A · CIK 0001397778 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 161,755

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · price: The price range for the aggregate amount sold by the direct holder is $80.00 - $80.10. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 127,602 shares of common stock and 34,153 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2019 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and will be reported at the time of vesting. The satisfaction of the 2017, 2018 and 2019 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020, February 2021 and February 2022, respectively, and will be reported at the time of vesting.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.